BTS #60 Linda Klumpers PhD on Rimonabant, CB1 Antagonists, Role of CB2

1:22:57
 
Share
 

Manage episode 297388029 series 2651926
By Natural Learning Enterprises, LLC, Natural Learning Enterprises, and LLC. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

In this behind-the-scenes episode we are joined once again by Dr. Linda Klumpers, a clinical pharmacologist that has been spending her professional career understanding how cannabinoids and cannabinoid receptors work in the body.

We spend this episode discussing the concept of CB1 receptor antagonists and the story of a hopeful drug from the 1990s, Rimonabant, that ended up teaching researchers a painful lesson about cannabinoid receptor pharmacology. We also discuss our limited understanding of CB2 receptors, the future of cannabinoid receptor antagonist drugs, and more!

Want to learn more about cannabinoid pharmacology? Dr. Klumpers and the team at Cannify has teamed up with Curious About Cannabis to produce a series of cannabinoid pharmacology courses and lecture videos available at the Curious About Cannabis Learning Center at www.cannabis-courses.com. Check out our Cannabinoid Pharmacology Basics course today and get 15% off with discount code “cacxcannify”

81 episodes